Experimental shot targets tumors directly in early trial
Disease control
Completed
This early-phase study tested an experimental drug called JCXH-211, which is injected directly into tumors. It involved 19 adults with advanced solid cancers that had stopped responding to standard treatments. The main goals were to check safety and find the right dose, while als…
Phase: PHASE1 • Sponsor: Immorna Biotherapeutics, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC